American Bio Medica Corp (ABMC) SEC Filing 10-K Annual report for the fiscal year ending Friday, December 31, 2010

American Bio Medica Corp

CIK: 1576940 Ticker: ABMC

View differences made from one year to another to evaluate American Bio Medica Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Bio Medica Corp.


Assess how American Bio Medica Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

American Bio Medica Corp provided additional information to their SEC Filing as exhibits

Ticker: ABMC
CIK: 896747
Form Type: 10-K Annual Report
Accession Number: 0001144204-11-017192
Submitted to the SEC: Fri Mar 25 2011 3:56:10 PM EST
Accepted by the SEC: Fri Mar 25 2011
Period: Friday, December 31, 2010
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: